Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $45 million.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $45 million.